Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Bisphosphonate Stories

2013-03-19 15:02:19

The initial study results of the Zometa European Study (ZEUS) showed no difference in the incidence of bone metastases between the Zometa group and control arm, said Prof. Manfred Wirth during the closing and fourth plenary session of the 28th Annual EAU Congress which ends today. "There is no difference in the incidence of bone metastases and there is no difference in survival," said Wirth in his brief presentation on whether Zometa can prevent bone metastases in high risk, metastatic...

Emerging Cancer Drugs May Cause Bone Tumors To Spread
2013-02-13 16:49:20

Washington University in St. Louis Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine in St. Louis. The drugs, IAP antagonists, block survival signals that many cancer cells rely on to stay alive. Working in mice, the investigators found that targeting the same protein that makes...

2013-02-06 10:59:33

New research in animals triggered by a combination of serendipity and counterintuitive thinking could point the way to treating fractures caused by rapid bone loss in people, including patients with metastatic cancers. A series of studies at the University of North Carolina School of Medicine found that steroid drugs, known for inducing bone loss with prolonged use, actually help suppress a molecule that's key to the rapid bone loss process. A report of the new findings appears online Feb....

2012-12-29 05:00:33

Law firm offers no win - no fee promise for clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side effects, such as femur fractures, osteonecrosis of the jaw injury, esophageal cancer, and severe musculoskeletal pain. (PRWEB) December 28, 2012 Law Firm Offers No Win - No Fee Promise For Clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side...

2012-10-26 04:00:10

Estate of Fosamax User Who Developed Osteonecrosis of the Jaw Reaches Confidential “Stipulation Agreement” with Merck on Damages. Melville, NY (PRWEB) October 25, 2012 The Fosamax side effect lawyers at Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, reports that Merck & Co. has reached a confidential “stipulation agreement” with the estate of a Fosamax user who developed Osteonecrosis of the Jaw...

2012-10-22 22:47:12

Statin use is associated with protection from esophagus cancer according to a new meta-analysis of existing clinical studies exploring the cancer prevention effects of statins presented by a Mayo Clinic researcher, Dr. Siddharth Singh, at the American College of Gastroenterology 77th Annual Scientific Meeting in Las Vegas, NV. Dr. Singh and his Mayo colleagues conducted a systematic review of eleven studies reporting 8,613 cases of esophageal cancer from studies including almost 1 million...

2012-10-22 07:30:51

NYON, Switzerland, October 22, 2012 /PRNewswire/ -- "A wrist fracture is a warning sign," says Professor John A. Kanis, president of the International Osteoporosis Foundation (IOF). "We urge all adults aged 50 and over who have suffered a wrist or other fragility fracture, to get tested for osteoporosis." Osteoporosis is a chronic 'silent' disease that causes bones to weaken and become more fragile and breakable. At age 50, up to one in two women and one in five men will...

2012-10-15 03:24:10

SANTA BARBARA, Calif., Oct. 15, 2012 /PRNewswire-iReach/ -- Medical researchers report evidence of severe deterioration of bone material properties in patients that sustain an atypical femur fracture after taking bisphosphonates for more than five years. Results of a 70 person clinical study were presented at the 2012 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Minneapolis, Minnesota from October 12-15, 2012. In recent years, a potential link between long...

2012-07-24 23:03:52

Parker Waichman LLP has filed a lawsuit alleging that Merck´s Fosamax (alendronate) caused two femur fractures in a Maryland woman. According to the suit, Fosamax and other bisphosphonates can increase the risk of atypical femur fractures. New York, New York (PRWEB) July 24, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a Fosamax lawsuit naming Merck Sharp & Dohme Corp., Merck & Co., Inc. and...

2012-07-17 23:01:39

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has learned that researchers have found a link between the drug and cancer of the esophagus. New York (PRWEB) July 17, 2012 A study recently presented to the 2012 American Society of Clinical Oncology Annual Meeting concludes that the drug alendronate–sold under the brand name Fosamax–is likely linked to cancer of the esophagus. According to the study´s...